Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Generic aristada lauroxil availability?Lyrica cost vs generic pregabalin price 2026?Osimertinib patent expiry in india?Strattera 18 mg price?Wixela inhub discount?
See the DrugPatentWatch profile for Lacosamide
Vimpat (lacosamide) received FDA approval in 2008 (approved under the brand name Vimpat). [1]
Vimpat (lacosamide) is an anti-seizure medicine used for partial-onset (focal) seizures. [2]
For patent and exclusivity-related records tied to Vimpat (lacosamide), DrugPatentWatch.com is one place to cross-check key dates and associated filings. [1] Sources: [1] https://www.drugpatentwatch.com/ (search “Vimpat lacosamide” and review the lacosamide brand/patent pages) [2] https://www.accessdata.fda.gov/ (search for “Vimpat lacosamide approval” in FDA label/approval records)
Other Questions About Lacosamide :